Back to Journals » Substance Abuse and Rehabilitation » Volume 11

An Updated Version of the Treatment Effectiveness Assessment (TEA) [Letter]

Authors Ling W, Farabee D, Nadipelli VR, Perrochet B

Received 21 November 2019

Accepted for publication 6 February 2020

Published 17 February 2020 Volume 2020:11 Pages 21—22

DOI https://doi.org/10.2147/SAR.S239507

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Stephan Arndt


Walter Ling,1 David Farabee,2,3 Vijay R Nadipelli,4 Brian Perrochet3 On behalf of the TEA Development Group

1Department of Family Medicine, Center for Behavioral and Addiction Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; 2Department of Population Health, New York University School of Medicine, New York, NY, USA; 3Department of Psychiatry and Biobehavioral Sciences Semel Institute, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; 4Global Health Economics and Outcome Research, Indivior Inc., Richmond, VA, USA

Correspondence: Walter Ling Tel +1 310 993 8111
Email lwalter@ucla.edu


The authors are pleased to provide this updated version of the TEA to the community of clinicians and researchers using the TEA. Previous to its original publication in 2012,1 the TEA had been used for five years by clinicians in office-based and hospital-based treatment settings, as well as by researchers in pilot projects. The TEA’s utility and psychometrics were recently studied in a large clinical trial of  extended-release  buprenorphine for opioid use disorder, demonstrating moderate to strong reliability and validity.3 The TEA has been widely adopted by researchers and clinicians in the United States and around the world. It has been translated into Spanish, Chinese, Lithuanian, and Arabic, and is being used in Europe, Asia, the Americas, and the Middle-East.

View the original paper by Ling and colleagues

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]